HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Michael R Horsman Selected Research

Nimorazole

1/2015Targeting tumour hypoxia to improve outcome of stereotactic radiotherapy.
9/2013Radiosensitivity and effect of hypoxia in HPV positive head and neck cancer cells.
10/2005Plasma osteopontin, hypoxia, and response to the hypoxia sensitiser nimorazole in radiotherapy of head and neck cancer: results from the DAHANCA 5 randomised double-blind placebo-controlled trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Michael R Horsman Research Topics

Disease

57Neoplasms (Cancer)
05/2021 - 05/2002
36Hypoxia (Hypoxemia)
11/2020 - 01/2002
22Carcinoma (Carcinomatosis)
07/2020 - 01/2002
6Necrosis
10/2019 - 11/2003
3Hyperthermia
01/2016 - 01/2015
3Head and Neck Neoplasms (Head and Neck Cancer)
01/2016 - 10/2005
2Sarcoma (Soft Tissue Sarcoma)
01/2016 - 11/2011
2Breast Neoplasms (Breast Cancer)
11/2015 - 12/2012
2Radiation Fibrosis Syndrome (Radiation Fibrosis)
01/2015 - 11/2013
2Squamous Cell Carcinoma (Epidermoid Carcinoma)
09/2009 - 07/2005
1Adenocarcinoma
05/2021
1Inflammation (Inflammations)
10/2020
1Uterine Cervical Neoplasms (Cancer of the Cervix)
01/2016
1Prostatic Neoplasms (Prostate Cancer)
11/2015
1Neoplasm Metastasis (Metastasis)
05/2015
1Fibrosis (Cirrhosis)
01/2015
1Acidosis
01/2015
1Hypertension (High Blood Pressure)
01/2011
1Urinary Bladder Neoplasms (Bladder Cancer)
11/2010
1Glioma (Gliomas)
08/2010
1Glioblastoma (Glioblastoma Multiforme)
08/2010

Drug/Important Bio-Agent (IBA)

22Oxygen (Dioxygen)IBA
05/2021 - 11/2002
14fosbretabulin (combretastatin A4)IBA
07/2020 - 05/2002
9pimonidazoleIBA
05/2021 - 03/2008
7Biological ProductsIBA
11/2018 - 06/2004
7Pharmaceutical PreparationsIBA
01/2017 - 09/2005
6Phosphates (Orthophosphate)IBA
07/2020 - 02/2007
6vadimezanIBA
12/2014 - 05/2002
5fluoroazomycin arabinosideIBA
05/2021 - 03/2008
5combretastatinIBA
05/2015 - 03/2005
4Waste Products (Waste Product)IBA
11/2020 - 04/2004
4Biomarkers (Surrogate Marker)IBA
01/2016 - 12/2008
4OsteopontinIBA
06/2007 - 10/2005
3Adenosine Triphosphate (ATP)IBA
11/2020 - 06/2008
3Oxi 4503IBA
07/2020 - 01/2015
3Lactic Acid (Lactate)FDA LinkGeneric
11/2017 - 01/2015
3Proteins (Proteins, Gene)FDA Link
01/2016 - 09/2009
3NimorazoleIBA
01/2015 - 10/2005
3Niacinamide (Nicotinamide)FDA LinkGeneric
01/2015 - 05/2002
3Messenger RNA (mRNA)IBA
02/2011 - 08/2006
3Hydralazine (Apresoline)FDA LinkGeneric
01/2011 - 05/2002
3Glucose (Dextrose)FDA LinkGeneric
12/2008 - 07/2005
3N-acetylcochinol-O-phosphateIBA
01/2006 - 11/2003
3fluoromisonidazoleIBA
07/2005 - 01/2002
2IonsIBA
01/2021 - 01/2015
2CarbonIBA
01/2021 - 01/2015
2Pyruvic Acid (Pyruvate)IBA
11/2017 - 01/2015
2Contrast MediaIBA
11/2017 - 03/2005
2Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
05/2017 - 06/2008
2Cathepsin LIBA
11/2015 - 12/2012
1ProdrugsIBA
11/2020
1CytokinesIBA
10/2020
1Polystyrenes (Polystyrene)IBA
06/2020
1Polyethylene (Polythene)IBA
06/2020
1Bicarbonates (Hydrogen Carbonate)IBA
11/2017
1antineoplaston A10 (A 10)IBA
11/2017
1Blood Glucose (Blood Sugar)IBA
05/2017
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
01/2017
1Phenformin (Fenformin)IBA
01/2017
1BiguanidesIBA
01/2017
1Metformin (Glucophage)FDA LinkGeneric
01/2017
1MisonidazoleIBA
01/2016
1matrigelIBA
11/2015
1Dihydrotachysterol (AT 10)IBA
11/2015
1ThiosemicarbazonesIBA
11/2015
1ClayIBA
05/2015
1Doxorubicin (Adriamycin)FDA LinkGeneric
05/2015
1carbogenIBA
01/2015
1Ribosomal Proteins (Ribosomal Protein)IBA
01/2015
1Protein Isoforms (Isoforms)IBA
01/2015
1Peptide Initiation Factors (Initiation Factor)IBA
01/2015
1Complement System Proteins (Complement)IBA
01/2015
1IndiumIBA
11/2014
15-(6)-carboxyfluorescein diacetate succinimidyl ester (CFSE)IBA
11/2014
1EstersIBA
11/2014
1Small Interfering RNA (siRNA)IBA
11/2013
1ChitosanIBA
11/2013
1KGP94IBA
12/2012
1Collagen Type I (Type I Collagen)IBA
12/2012
1NPI 2358IBA
11/2011
1Antihypertensive Agents (Antihypertensives)IBA
01/2011
1Hemoglobins (Hemoglobin)IBA
01/2011
1Matrix Metalloproteinase 9 (Gelatinase B)IBA
11/2010
1Nitric Oxide (Nitrogen Monoxide)FDA Link
10/2010
1Arginine (L-Arginine)FDA Link
10/2010
1Bevacizumab (Avastin)FDA Link
08/2010
1Neutralizing AntibodiesIBA
08/2010
1ErbB Receptors (EGF Receptor)IBA
08/2010
1Irinotecan (Camptosar)FDA LinkGeneric
08/2010
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
08/2010
1Cetuximab (Erbitux)FDA Link
08/2010

Therapy/Procedure

17Radiotherapy
11/2020 - 11/2002
14Therapeutics
11/2020 - 11/2002
8Electrodes (Electrode)
01/2015 - 01/2002
6Aftercare (After-Treatment)
07/2020 - 05/2002
3Lasers (Laser)
05/2021 - 05/2002
3Drug Therapy (Chemotherapy)
01/2016 - 06/2006
2Nutritional Support (Artificial Feeding)
09/2015 - 04/2004
1Anesthesia
05/2017
1Injections
05/2017